Open Access

Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis

  • Authors:
    • Panpan Li
    • Juanjuan Zhang
    • Fuchun Li
    • Yanyan Yu
    • Yinghong Chen
  • View Affiliations

  • Published online on: May 21, 2019     https://doi.org/10.3892/ijmm.2019.4205
  • Pages: 135-144
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Recently, the use of low‑intensity ultrasound (LIUS) combined with chemotherapeutic agents is widely used in clinical practice, mainly for the treatment of cancer; however, the mechanisms as to how LIUS enhances the antitumor effects of these agents are not fully understood. The aim of the present study was to explore the synergistic antitumor effects and mechanisms of cisplatin (DDP) combined with LIUS (LIUS‑DDP) in hepatocellular carcinoma (HCC). We reported that LIUS effectively enhanced Huh7 and HCCLM3 cell sensitivity to a low concentration of DDP. Reverse transcription‑quantitative polymerase chain reaction analysis revealed that LIUS could increase the expression of microRNA‑34a (miR‑34a) in HCC cells following DDP treatment. In addition, LIUS‑DDP significantly increased intracellular reactive oxygen species (ROS) levels in vitro, and the upregulation of miR‑34a induced by LIUS‑DDP was reversed by the ROS scavenger N‑acetylcysteine, suggesting that LIUS upregulates the expression of miR‑34a via production of ROS. In addition, knockdown of miR‑34a in HCC cells significantly suppressed the synergistic effects of LIUS‑DDP treatment. Conversely, overexpression of miR‑34a enhanced these synergistic effects. The results of a dual‑luciferase assay indicated that c‑Met, a well‑known oncogene, was a target of miR‑34a. We also determined that LIUS‑DDP treatment inhibited the expression of c‑Met, possibly due to increased ROS production, which upregulated miR‑34a expression. Furthermore, overexpression of c‑Met reversed the synergistic effects of LIUS‑DDP treatment. Our findings suggest that LIUS could enhance the chemosensitivity of HCC cells to DDP by altering the miR‑34a/c‑Met axis. Therefore, DDP combined with LIUS may be a potential therapeutic application for the clinical treatment of patients with HCC.
View Figures
View References

Related Articles

Journal Cover

July-2019
Volume 44 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li P, Zhang J, Li F, Yu Y and Chen Y: Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis. Int J Mol Med 44: 135-144, 2019.
APA
Li, P., Zhang, J., Li, F., Yu, Y., & Chen, Y. (2019). Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis. International Journal of Molecular Medicine, 44, 135-144. https://doi.org/10.3892/ijmm.2019.4205
MLA
Li, P., Zhang, J., Li, F., Yu, Y., Chen, Y."Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis". International Journal of Molecular Medicine 44.1 (2019): 135-144.
Chicago
Li, P., Zhang, J., Li, F., Yu, Y., Chen, Y."Low‑intensity ultrasound enhances the chemosensitivity of hepatocellular carcinoma cells to cisplatin via altering the miR‑34a/c‑Met axis". International Journal of Molecular Medicine 44, no. 1 (2019): 135-144. https://doi.org/10.3892/ijmm.2019.4205